Semaglutide and Tirzepatide are new, FDA-approved treatments designed for weight loss in overweight and obese patients. As GLP-1 receptor agonists, they help manage hunger and regulate blood sugar. Research indicates that those taking these weekly injections could shed up to 15% of their body weight in as little as 6 months.
A full evaluation is required before starting weight loss management, but it’s important to understand that outcomes can differ for each person.
Let’s get started on your journey, tap below to book your evaluation and see where it takes you!
Note: Notify your provider if there’s any noticeable redness or swelling at the injection site
Powered by She Creates Brands
Powered by She Creates Brands